sur AFYREN (EPA:ALAFY)
AFYREN NEOXY Achieves First Significant Revenue in 2025
On January 15, 2026, AFYREN announced that its joint venture, AFYREN NEOXY, generated its first significant revenue in 2025, a milestone for the company's bio-based production. This comes after producing around 400 tons of bio-based acids and associated fertilizers, resulting in sales of approximately €1 million, with €0.5 million invoiced by the year's end.
The year 2025 was marked by AFYREN's shift to continuous production, despite temporary pauses mid-year to tackle operational bottlenecks. Production surged in the last two months, contributing heavily to the annual output. The company anticipates further growth in 2026.
AFYREN NEOXY successfully supplied products to nine clients, underpinned by existing contracts and the acquisition of new customers across diverse sectors, including Flavors and Fragrances and Life Sciences. All production volumes have secured sales outlets, indicating strong market confidence.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de AFYREN